|
Over the past couple years we have witnessed rapid advances in genetic testing for hereditary
breast cancer. This course will lead attendees through a comprehensive review of the process of
hereditary breast cancer risk assessment, genetic testing, and the translation of this information
into personalized cancer surveillance and risk reduction. Focus will be placed on incorporating the
latest data and testing options into your high-risk clinic. This will include the implication of breast
tumor genomic testing on inherited risk assessment and the challenges surrounding multi-gene
panel testing as it applies to risk and management interpretation. The attendees will have the
opportunity to submit challenging cases from their practices to be discussed by experts in the
field.
The course is applicable to a wide range of healthcare practitioners including nurses/nurse navigators, gynecologists, oncologists, surgeons, genetic counselors, primary care physicians and social workers.
Register early to guarantee your space!
This course is sponsored in part by Myriad.
|
